1. Home
  2. SEI vs NVAX Comparison

SEI vs NVAX Comparison

Compare SEI & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEI
  • NVAX
  • Stock Information
  • Founded
  • SEI 2014
  • NVAX 1987
  • Country
  • SEI United States
  • NVAX United States
  • Employees
  • SEI N/A
  • NVAX N/A
  • Industry
  • SEI
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SEI
  • NVAX Health Care
  • Exchange
  • SEI NYSE
  • NVAX Nasdaq
  • Market Cap
  • SEI 1.1B
  • NVAX 1.3B
  • IPO Year
  • SEI 2017
  • NVAX 1995
  • Fundamental
  • Price
  • SEI $35.95
  • NVAX $7.99
  • Analyst Decision
  • SEI Strong Buy
  • NVAX Buy
  • Analyst Count
  • SEI 2
  • NVAX 6
  • Target Price
  • SEI $42.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • SEI 1.2M
  • NVAX 3.7M
  • Earning Date
  • SEI 02-20-2025
  • NVAX 02-27-2025
  • Dividend Yield
  • SEI 1.33%
  • NVAX N/A
  • EPS Growth
  • SEI N/A
  • NVAX N/A
  • EPS
  • SEI 0.50
  • NVAX N/A
  • Revenue
  • SEI $313,091,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • SEI $59.87
  • NVAX N/A
  • Revenue Next Year
  • SEI $28.37
  • NVAX N/A
  • P/E Ratio
  • SEI $71.92
  • NVAX N/A
  • Revenue Growth
  • SEI 6.88
  • NVAX N/A
  • 52 Week Low
  • SEI $7.49
  • NVAX $3.81
  • 52 Week High
  • SEI $39.03
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • SEI N/A
  • NVAX 42.04
  • Support Level
  • SEI N/A
  • NVAX $7.70
  • Resistance Level
  • SEI N/A
  • NVAX $8.54
  • Average True Range (ATR)
  • SEI 0.00
  • NVAX 0.39
  • MACD
  • SEI 0.00
  • NVAX -0.04
  • Stochastic Oscillator
  • SEI 0.00
  • NVAX 23.58

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: